The decrease was driven by Cash used in operations of $55,800,000 year to date, capital expenditures of $9,400,000 primarily related to additional manufacturing investments and showroom expansion, partially offset by cash Provided of $57,000,000 received from the public stock offering completed in February of 2023. At September 30, we had no amounts outstanding on our ABL facility. Inventories at September 30 were $72,100,000 compared With $73,200,000 at December 31, 2022. Now let me turn my comments To our outlook for the remainder of the year, given the current state of the mattress industry along with our performance year to date, we're moderating our outlook We now expect full year net revenue in the range of $510,000,000 to $520,000,000 And adjusted EBITDA loss between $55,000,000 $65,000,000 While we narrowed our full year revenue range to $10,000,000 from $30,000,000 We are maintaining our $10,000,000 range for adjusted EBITDA due to the variability in transition costs related to the product launches, which are impacting our gross margins this year. This updated outlook implies 4th quarter revenue in the range of $145,000,000 to 100 and $5,000,000 and an adjusted EBITDA loss of between $20,000,000 $10,000,000 We're encouraged with the sequential momentum we're seeing in the top However, our adjusted EBITDA has underperformed our expectations.